Trinity Biotech reports findings from latest pre-pivotal trial on CGM system
Trinity Biotech (TRIB) announced new findings from its latest pre-pivotal trial, highlighting significant improvements in first-day performance ...
drugdeliverybusiness12d
Trinity Biotech expects to submit ‘disruptive’ next-gen CGM to FDA in 2026
(Nasdaq:TRIB) announced new pre-pivotal clinical data supporting its next-generation continuous glucose monitor (CGM) system.
Yahoo Finance8d
Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
The first 24 hours of CGM wear have been a persistent weak spot across the industry, with sensor accuracy often fluctuating due to the body’s natural response to insertion. These advancements ...
WebMD1y
How Does a Continuous Glucose Monitor Work?
A continuous glucose monitor, or CGM, is a system that helps some people ... A thin, disposable needle called a sensor stays under your skin. The sensor is removed and changed every few days.
Morningstar17d
Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology
By using more durable, reusable components, enabled by Trinity’s proprietary self-inserting sensor technology, the Trinity CGM is designed to deliver care at a significantly lower cost than ...
Business Insider17d
Trinity Biotech announces results from pre-pivotal trial for CGM system
“We believe that our patented technology-featuring a modular, eco-friendly design and cutting-edge sensor performance-represents a paradigm shift in the CGM market, which is projected to exceed ...